Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash from Investing Activities: 2021-2022

Historic Cash from Investing Activities for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2022 value amounting to -$17.0 million.

  • Milestone Pharmaceuticals' Cash from Investing Activities fell 213.43% to -$17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$57.1 million, marking a year-over-year decrease of 181.61%. This contributed to the annual value of $8.3 million for FY2024, which is 74.16% up from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Cash from Investing Activities of -$17.0 million as of Q4 2022, which was up 0.21% from -$17.1 million recorded in Q3 2022.
  • Milestone Pharmaceuticals' 5-year Cash from Investing Activities high stood at $23.0 million for Q3 2021, and its period low was -$17.1 million during Q3 2022.
  • Over the past 2 years, Milestone Pharmaceuticals' median Cash from Investing Activities value was $2.0 million (recorded in 2021), while the average stood at $1.6 million.
  • Data for Milestone Pharmaceuticals' Cash from Investing Activities shows a maximum YoY tumbled of 213.43% (in 2022) over the last 5 years.
  • Over the past 2 years, Milestone Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at $15.0 million in 2021, then slumped by 213.43% to -$17.0 million in 2022.
  • Its Cash from Investing Activities was -$17.0 million in Q4 2022, compared to -$17.1 million in Q3 2022 and -$15.1 million in Q2 2022.